Handbook of Pharmaceutical Manufacturing Formulations
Sarfaraz K. Niazi (Editor), %26laquo;Handbook of Pharmaceutical Manufacturing Formulations%26raquo;
6 Volumes | ISBN: 0849317525 | 2004 Year | 2836 Pages | PDF | 13,3 Mb
This 6-Volume Set is the first of its kind published in the pharmaceutical literature and is a must collection for all pharmaceutical manufacturers, educational institutions and regulatory authorities.
Volume One:Compressed Solid Products
Volume Two:Uncompressed Drug Products
Volume Three: Liquid Products
Volume Four: Semi-Solid Products
Volume Five: Over the Counter Products
Volume Six: Sterile Products
Pharmaceutical formulations remain as much an art today as they have evolved into complex science. With exponential growth of generic formulations, the need for ready formulations has increased.
An authoritative practical guide in the art and science of formulating drugs, the six-volume handbook contains the Bill of Materials and Manufacturing Directions for over 2000 drug formulations, including a number of biotechnology and patented drugs.
The author has painstakingly assembled these volumes from FDA New Drug Applications, patent applications and other sources of generic and proprietary formulations, all supplemented by his 30-plus years of experience in pharmaceutical formulations.
Each volume of the series is divided into two parts:
the section on regulatory and manufacturing guidelines
the section on formulations
The series provides chapters on issues related to generic manufacturing of drugs including:
%26#8226; cGMP compliance
%26#8226; pre-approval inspections
%26#8226; stability testing
%26#8226; bioequivalence testing
%26#8226; packaging commodity development
%26#8226; changes to aNDAs
%26#8226; SUPAC for equipment
%26#8226; and more
Each category of drug formulations, as classified in a separate volume, is analyzed for the common difficulties in formulating drugs.
This 6-Volume Set is the first of its kind published in the pharmaceutical literature and is a must collection for all pharmaceutical manufacturers, educational institutions and regulatory authorities.
Companies with large formulation teams will find this series an excellent platform for benchmarking their own products and the generic companies will find it an excellent source of information prior to embarking on formulating drugs coming off patent; it will mean getting on the filing of the aNDAs in the shortest possible time.
http://rapidshare.de/files/32270083/HoPMF.rarhttp://depositfiles.com/files/243861/HoPMF.rar.htmlhttp://mihd.net/7.1652/HoPMF.rar.html 上一篇：Perry's Chemical Engineers' Handbook 下一篇：反相HPLC法测定天麻中药材中天麻素的含量
